Text Size

Infections After Renal Transplantation: Diseases Pattern in Hong Kong

This study has been completed.
Sponsor:
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT00498017
First received: July 6, 2007
Last updated: June 14, 2011
Last verified: June 2011
History of Changes
  Purpose

Infections are the most feared complications developing in patient who had had kidney transplantation. The aim of this study is to document the local disease pattern among this group of patients.


Condition
Kidney Transplantation
Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Infections After Renal Transplantation: Diseases Pattern in Hong Kong

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hospital Authority, Hong Kong:

Estimated Enrollment: 58
Study Start Date: July 2006
Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Sampling Method:   Non-Probability Sample
Study Population

Over a period of 4.5 years, between 1/1/2000 and 30/6/2005, there were totally 58 new cases in our renal transplantation clinic. 36 of them were male, 22 of them were female (Male to female ratio is 1.64:1). All were single-organ recipients. Majority of them (57/58 or 98.3%) were receiving their first renal transplantation, the only exception was a women receiving her second renal transplantation during the study period. Majority (57/48 or 98.3%) of them were cadaveric renal transplantation (CRT). One living-related renal transplantation (LDRT) had been performed in Hong Kong during the study period. Majority of the renal transplantation were performed in Mainland China (48/58 or 82.8%), whilst the remaining 10 operations (17.2%) were performed in Hong Kong.

Criteria

Inclusion Criteria:

  • All living-related or cadaveric renal transplantation episodes (including preemptive ones) performed in the Hong Kong Special Administration Region (HKSAR), Mainland China or overseas during the period 1/1/2000 to 30/6/2005

Exclusion Criteria:

  • multiple organ recipients, incomplete records and lost to follow-up, including those cases who have been taken over by other renal centres
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498017

Locations
China
Princess Margaret Hospital
Hong Kong, China
Caritas Medical Centre
Hong Kong, China
Sponsors and Collaborators
Hospital Authority, Hong Kong
Investigators
Principal Investigator: Sze Kit Yuen, Dr Department of Medicine & Geriatrics, ICU, Caritas Medical Centre
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00498017     History of Changes
Other Study ID Numbers: KW/EX/06-044, HARECCTR0500060
Study First Received: July 6, 2007
Last Updated: June 14, 2011
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Hospital Authority, Hong Kong:
Infections

ClinicalTrials.gov processed this record on June 18, 2013